EORTC Cutaneous Lymphoma Task Force

European Journal of Cancer

Volumn 38, Issue SUPPL. 4, 2002, Pages 60-64

  Knobler, R ^a   Burg, G ^b   Whittaker, S ^c   Baila, L ^d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d EORTC DATA CENTER   (Belgium)

Author keywords

Classification; Cutaneous lymphoma; EORTC; Lymphoma registry

Indexed keywords

ALPHA2A INTERFERON; ETRETIN;

CANCER CLASSIFICATION; CANCER STAGING; CLINICAL TRIAL; CYTOLOGY; DIAGNOSTIC ACCURACY; GOOD CLINICAL PRACTICE; HEALTH CARE ORGANIZATION; HISTOLOGY; HUMAN; MYCOSIS FUNGOIDES; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PUVA; REVIEW; SEZARY SYNDROME; SKIN LYMPHOMA; T CELL LYMPHOMA;

EID: 0036179357     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0959-8049(01)00466-x     Document Type: Review

References (8)

1. EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organisation for Research and Treatment of Cancer
2. Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sezary syndrome
3. Prospective randomised multicentre clinical trial on the use of interferon alpha-2a plus acitretin versus interferon alpha-2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II
4. EORTC classification for primary cutaneous lymphomas: The best guide to good clinical management. European Organisation for Research and Treatment of Cancer
5. Interrater and intrarater variabilities in the evaluation of cutaneous lymphoproliferative T-cell infiltrates. EORTC-Cutaneous Lymphoma Project Group
6. Interrater and intrarater reliability of histologic criteria in early cutaneous T-cell lymphoma. An EORTC Cutaneous Lymphoma Project Group study
7. Efficacy of histologic criteria for diagnosing early mycosis fungoides: An EORTC cutaneous lymphoma study group investigation
8. Prognostic factors in primary cutaneous large B-cell lymphomas: A European multicenter study